Found: 11
Select item for more details and to access through your institution.
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e799, doi. 10.1093/cid/ciaa1510
- By:
- Publication type:
- Article
Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 4, p. n/a, doi. 10.1111/tid.12702
- By:
- Publication type:
- Article
Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.
- Published in:
- Journal of Surgical Oncology, 2015, v. 112, n. 1, p. 72, doi. 10.1002/jso.23944
- By:
- Publication type:
- Article
Post-transplant lymphoproliferative disorder in liver transplant recipients: Characteristics, management and outcome from a single-centre experience with >1000 liver transplantations.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2015, v. 29, n. 8, p. 417, doi. 10.1155/2015/517359
- By:
- Publication type:
- Article
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2014, v. 28, n. 1, p. 41, doi. 10.1155/2014/839014
- By:
- Publication type:
- Article
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
- Published in:
- Transplant International, 2017, v. 30, n. 11, p. 1140, doi. 10.1111/tri.13008
- By:
- Publication type:
- Article
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.
- Published in:
- Experimental & Clinical Transplantation, 2019, v. 17, n. 1, p. 59, doi. 10.6002/ect.2017.0201
- By:
- Publication type:
- Article
The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.
- Published in:
- Clinical Transplantation, 2012, v. 26, n. 5, p. E561, doi. 10.1111/ctr.12022
- By:
- Publication type:
- Article
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2014, v. 13, n. 5, p. 525, doi. 10.1016/s1665-2681(19)31252-9
- By:
- Publication type:
- Article
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
- Published in:
- Liver International, 2005, v. 25, n. 4, p. 723, doi. 10.1111/j.1478-3231.2005.01107.x
- By:
- Publication type:
- Article
Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
- Published in:
- Transplant International, 2013, v. 26, n. 1, p. 42, doi. 10.1111/j.1432-2277.2012.01571.x
- By:
- Publication type:
- Article